SANCUSO is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Kyowa Kirin, Inc.. The primary component is Granisetron.
| Product ID | 42747-726_1623fcfc-ee32-4e20-9e8e-a6767a5c2e13 | 
| NDC | 42747-726 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | SANCUSO | 
| Generic Name | Granisetron | 
| Dosage Form | Patch | 
| Route of Administration | TRANSDERMAL | 
| Marketing Start Date | 2008-09-12 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022198 | 
| Labeler Name | Kyowa Kirin, Inc. | 
| Substance Name | GRANISETRON | 
| Active Ingredient Strength | 3 mg/24h | 
| Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2008-09-12 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022198 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2008-09-12 | 
| Ingredient | Strength | 
|---|---|
| GRANISETRON | 3.1 mg/24h | 
| SPL SET ID: | ba44e7d8-0c71-4eb9-a951-3d91038293c5 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 42747-726 | SANCUSO | granisetron | 
| 66758-035 | Granisetron | Granisetron | 
| 66758-036 | Granisetron | Granisetron | 
| 47426-101 | SUSTOL | granisetron | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SANCUSO  79064017  3744866 Live/Registered  | 
        Kyowa Kirin, Inc.  2008-12-19  | 
![]() SANCUSO  76460343  2814630 Live/Registered  | 
        STRAKAN INTERNATIONAL S.A.  2002-10-17  |